American Pediatric Society honors Dr. Bruce D. Gelb with 2026 APS John Howland Award

A pioneering pediatric cardiologist and geneticist is honored for transformative contributions to child health and the field of pediatrics

2025-10-28

(Press-News.org) HOUSTON, Oct. 28, 2025 – The American Pediatric Society (APS) proudly announces Bruce D. Gelb, as the recipient of the 2026 APS John Howland Award, the highest honor bestowed by the Society. Widely regarded as the most prestigious recognition in academic pediatrics, the award celebrates Dr. Gelb’s outstanding contributions to advancing child health and the field of pediatrics.

Established in 1952 to honor clinician-scientist John Howland, MD, the APS John Howland Award annually recognizes individuals for their distinguished service to pediatrics. Dr. Gelb will be formally honored during the APS Presidential Plenary at the Pediatric Academic Societies (PAS) 2026 Meeting, taking place in Boston, MA, from April 24 to April 27.

Dr. Bruce D. Gelb, a pioneering pediatric cardiologist and geneticist from the Icahn School of Medicine at Mount Sinai, is known for his transformative research uncovering the genetic causes of congenital heart disease (CHD) and related disorders. His early work, supported by the National Institutes of Health, helped establish the molecular foundations of CHD and led to landmark discoveries explaining why some children are born with heart defects. Among his most influential contributions was identifying the first genetic cause of Noonan syndrome, work that paved the way for understanding a broader group of developmental conditions now known as the RASopathies. These insights have shaped how physicians worldwide diagnose, predict, and treat these disorders.

“Dr. Gelb exemplifies the spirit of the John Howland Award through his groundbreaking research, visionary leadership, and unwavering dedication to mentoring future leaders in pediatrics,” said Stephen R. Daniels, MD, PhD, President of the American Pediatric Society. “His work has profoundly shaped our understanding of congenital heart disease and developmental disorders, and his influence continues to elevate the field of pediatric medicine.

In addition, during his presidency of APS, he led a strategic plan process that transformed our organization into one of action, leveraging the expertise of our members to improve the health and well-being of children and adolescents.”

Beyond his scientific achievements, Dr. Gelb has been an exceptional leader and mentor. As the founding Director of the Mindich Child Health and Development Institute and Dean for Child Health Research at the Icahn School of Medicine at Mount Sinai, he has built a thriving research community dedicated to improving child health through innovation and collaboration. Under his leadership, the institute has expanded major initiatives in clinical research, health services, and artificial intelligence. Dr. Gelb has combined visionary science with a steadfast commitment to mentoring the next generation of physician-scientists, leaving an enduring legacy in pediatric medicine and molecular genetics.

Throughout his career, Dr. Gelb has been a dedicated leader in national academic medical organizations, with a particular focus on advancing pediatric research and advocacy. He served on the APS Council from 2012 to 2020, including a term as President. Dr. Gelb also played a pivotal role in the Pediatric Academic Societies (PAS) meetings, serving as Program Chair in 2010 and 2011. He later became the inaugural President of the newly formed PAS Board, where he was instrumental in establishing the organization’s bylaws and governance structure. Most recently, Dr. Gelb completed his term as President of the American Society of Human Genetics.

APS looks forward to celebrating Dr. Gelb’s achievements at the PAS 2026 Meeting, where his legacy will inspire the next generation of pediatric leaders.

###

About the American Pediatric Society

The American Pediatric Society (APS) founded in 1888 as the first pediatric society in North America, is a nonprofit organization dedicated to strengthening academic pediatrics. Through its mission to expand the workforce, nurture leaders, and develop innovative approaches to address child and adolescent health challenges, APS engages over 1,800 distinguished members who are recognized for their extraordinary achievements. Together, they work to advance the future of child health and the profession of pediatrics. For more information, please visit aps1888.org, and follow us on Facebook and Twitter.

Media Contact:
Lisa Thompson
Association Director
American Pediatric Society
(346) 980-9707
lthompson@aps1888.org

END

ELSE PRESS RELEASES FROM THIS DATE:

Leveraging COVID-19 lessons to prepare for the next pandemic

2025-10-28

The COVID-19 pandemic has provided researchers with a wealth of information on contemporary successes and failures in combating an emerging pathogen. This study outlines a total of 22 opportunities and strategies based on urban functionality and typology to help communities better prepare for and mitigate the effects of the next pandemic. Global pandemics have occurred throughout human history, including the bubonic plague, Spanish flu and COVID-19. While the viruses and other infectious agents that cause pandemics vary, one fact remains constant: Another pandemic will occur, and no one can predict exactly when it will happen. Professor ...

Mount Sinai awarded $4.5M BD2 grant to advance research on the biology of bipolar disorder

2025-10-28

The Icahn School of Medicine at Mount Sinai is pleased to announce it has received a three-year, $4.5 million grant from BD2: Breakthrough Discoveries for thriving with Bipolar Disorder to investigate the neural mechanisms underlying bipolar disorder and pioneer novel neuromodulation-based treatment strategies. The team will be led by Ignacio Saez, PhD, Associate Professor of Neuroscience, Neurosurgery, Neurology at the Icahn School of Medicine and Director of the Human Neurophysiology Laboratory at Mount Sinai. Dr. Saez and his team are part of a select ...

Global initiative to demonstrate operational excellence in Nigeria for metastatic colorectal cancer patients

2025-10-28

Today, the Innovative Cancer Medicines (ICM) initiative announced the enrollment of the first Nigerian patient in a pioneering demonstration project to provide an immunotherapy drug used to treat cancer. The goal of the initiative is to develop an approach that explores sustainable and effective administration of innovative immuno-oncology therapies in low- and middle-income countries. The ICM initiative is a collaboration between the Clinton Health Access Initiative (CHAI) and the Parker Institute for Cancer Immunotherapy (PICI), along with Bristol Myers Squibb (BMS) and Roche, working ...

AI produces shallower knowledge than web search

2025-10-28

Learning about a topic by interacting with AI chatbots like ChatGPT rather than following links provided by web search can produce shallower knowledge. Advice given on the basis of this shallow knowledge tends to be sparser, less original, and less likely to be adopted by others. Shiri Melumad and Jin Ho Yun conducted seven experiments with thousands of online participants who were randomly assigned to learn about various topics, including how to plant a vegetable garden, how to lead a healthier lifestyle, or how to cope with financial scams, using either large language models (LLMs) or traditional Google web search links. Participants ...

New study shows global decline in parental trust in childhood vaccines after COVID-19, contributing to increased measles outbreaks

2025-10-28

October 28, 2025 — An international study led by the Azrieli Faculty of Medicine in the Galilee at Bar-Ilan University reveals that the COVID-19 pandemic has contributed to a diminishing public trust in childhood vaccines, resulting in declining vaccination rates and a resurgence of preventable, life-threatening diseases such as measles. The findings come amid one of the most severe measles outbreaks in Israel in decades, with thousands of infections and multiple child deaths reported nationwide. Published in the peer-reviewed journal Vaccine, the study surveyed 2,047 parents with children born both before and after the pandemic ...

BD² awards $18 million in grants to advance research on the biology of bipolar disorder

2025-10-28

Washington, D.C. – Today, BD², or Breakthrough Discoveries for thriving with Bipolar Disorder, announced its third round of Discovery Research grants, totaling nearly $18 million – expanding a comprehensive global effort to examine the key mechanisms of bipolar disorder. Multidisciplinary teams of scientists and clinicians include leads from the Icahn School of Medicine at Mount Sinai, Mass General Brigham, Weill Cornell Medicine, and the University of Minnesota. These teams represent a unique cohort of successful Discovery Grantees, as they will all use neuromodulation to explore human neural circuitry in bipolar disorder. These teams will each ...

Opt-out organ donation policies might reduce organ supply

2025-10-28

Every day, 17 Americans die while waiting for an organ transplant. Opt-out organ donation policies, which enroll everyone into post-mortem donation programs by default unless people choose to opt out, have been touted as a way to increase the supply of desperately needed organs. But opt-out organ donation policies may reduce living organ donations, leaving systems no better supplied with lifesaving organs. Pascal Güntürkün and colleagues analyzed epidemiological data from 24 countries between 2000–2023 and conducted four experimental ...

Message from the oldest-living dogs to dogs and men: Gonad function fights frailty

2025-10-28

West Lafayette, Ind. – Frailty threatens older individuals because it increases their vulnerability to detrimental health outcomes, such as falling, longer hospitalization, or even shortened life expectancy. New research exploring the linkage between frailty and mortality risk points to retaining gonad function as a potent strategy to fight late-life frailty. The study conducted by scientists at the Gerald P. Murphy Cancer Foundation’s Center for Exceptional Longevity Studies was published last week in the peer-reviewed scientific journal Scientific Reports. The ...

Distinct brain features in football players may tell who is at risk of long-term traumatic disease

2025-10-28

Brain scans from American football players reveal subtle differences in the brain’s outer grooves when compared to scans from otherwise healthy men who never played contact or collision sports, a new study shows. Its authors say the findings could potentially predict which people are more at risk of chronic traumatic encephalopathy (CTE). Like many neurodegenerative diseases, CTE is known to worsen over time, and it afflicts many who play contact and collision sports that involve repeated hits to the head. Popular contact sports include soccer and basketball, while common collision sports are ...

Identifying safer implant designs for total hip replacement

2025-10-28

As populations continue to age, total hip replacement (THR) is becoming an increasingly common surgical procedure. Experts estimate that approximately one million THRs are performed each year worldwide. The surgery is often life-changing, as it can fully restore the function of the hip joint, reduce pain, and allow patients to walk and bear weight again. However, as with any major surgery, the procedure is not without risks, especially for older individuals with other health conditions. A significant complication following THR is a femoral fracture—a break in the thigh bone near the artificial hip joint. This ...

LAST 30 PRESS RELEASES:

“Proton‑iodine” regulation of protonated polyaniline catalyst for high‑performance electrolytic Zn‑I2 batteries

Directional three‑dimensional macroporous carbon foams decorated with WC1−x nanoparticles derived from salting‑out protein assemblies for highly effective electromagnetic absorption